401
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prognostic Significance of the Diameter of Superior Rectal Vein for Locally Advanced Rectal Cancer

, , & ORCID Icon
Article: CRC | Received 28 Apr 2023, Accepted 26 Sep 2023, Published online: 09 Nov 2023

References

  • Siegel RL , Miller KD , Fuchs HE , Jemal A . Cancer Statistics, 2021. CA Cancer J. Clin. 71(1), 7–33 (2021).
  • van Gijn W , Marijnen CA , Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 12(6), 575–582 (2011).
  • Sauer R , Liersch T , Merkel S et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J. Clin. Oncol. 30(16), 1926–1933 (2012).
  • Ivan CV , Mullineux JH , Verma R et al. Assessment of the inferior mesenteric vein diameter as a surrogate marker to evaluate response to neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma. Colorect. Dis. 19(12), 1076–1080 (2017).
  • Dujovny N , Quiros RM , Saclarides TJ . Anorectal anatomy and embryology. Surg. Oncol. Clinic. N. Am. 13(2), 277–293 (2004).
  • Wu CC , Lee RC , Chang CY . Prediction of lymphovascular invasion in rectal cancer by preoperative CT. Am. J. Roentgenol. 201(5), 985–992 (2013).
  • Li X , Song C , Cai H et al. Correlation between the diameter of superior rectal vein and inferior mesenteric vein and the lymph node metastasis of rectal carcinoma. J. Sun Yat-Sen Univ. (6), 538–544 (2017).
  • Kang KA , Jang KM , Kim SH , Kang TW , Cha DI . Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer. Clin. Radiol. 72(6), 473–481 (2017).
  • Song C , Shen B , Dong Z et al. Diameter of superior rectal vein - CT predictor of KRAS mutation in rectal carcinoma. Cancer Manag. Res. 12, 10919–10928 (2020).
  • Gursoy Coruh A , Peker E , Elhan A , Erden I , Erden A . Evaluation of extramural venous invasion by diffusion-weighted magnetic resonance imaging and computed tomography in rectal adenocarcinoma. Can. Assoc. Radiol. J. 70(4), 457–465 (2019).
  • Bakke KM , Meltzer S , Grøvik E et al. Sex differences and tumor blood flow from dynamic susceptibility contrast MRI are associated with treatment response after chemoradiation and long-term survival in rectal cancer. Radiology 297(2), 352–360 (2020).
  • Satoh A , Shuto K , Okazumi S et al. Role of perfusion CT in assessing tumor blood flow and malignancy level of gastric cancer. Dig. Surg. 27(4), 253–260 (2010).
  • Hayano K , Shuto K , Koda K , Yanagawa N , Okazumi S , Matsubara H . Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer. Dis. Colon Rectum 52(9), 1624–1629 (2009).
  • Polacheck WJ , Zervantonakis IK , Kamm RD . Tumor cell migration in complex microenvironments. Cell. Mol. Life Sci. 70(8), 1335–1356 (2013).
  • Sorg BS , Hardee ME , Agarwal N , Moeller BJ , Dewhirst MW . Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors. J. Biomed. Opt. 13(1), 014026 (2008).
  • Vaupel P , Mayer A , Hockel M . Tumor hypoxia and malignant progression. Methods Enzymol. 381, 335–354 (2004).
  • Vaupel P . Prognostic potential of the pre-therapeutic tumor oxygenation status. Adv. Exp. Med. Biol. 645, 241–246 (2009).
  • Vaupel P , Hockel M , Mayer A . Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal 9(8), 1221–1235 (2007).
  • Gilkes DM , Semenza GL , Wirtz D . Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat. Rev. Cancer 14(6), 430–439 (2014).
  • Lee KE . Hypoxia as a regulator of tumor stroma and metastasis. Am. J. Physiol. Cell Physiol. 324(1), C10–C13 (2023).
  • Gupta GP , Massague J . Cancer metastasis: building a framework. Cell 127(4), 679–695 (2006).
  • Yao X , Yang SX , Song XH , Cui YC , Ye YJ , Wang Y . Prognostic significance of computed tomography-detected extramural vascular invasion in colon cancer. World J. Gastroenterol. 22(31), 7157–7165 (2016).
  • Dighe S , Swift I , Magill L et al. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. Color. Dis. 14(4), 438–444 (2012).
  • Chand M , Swift RI , Tekkis PP , Chau I , Brown G . Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br. J. Cancer 110(1), 19–25 (2014).
  • Zhang XY , Wang S , Li XT et al. MRI of extramural venous invasion in locally advanced rectal cancer: relationship to tumor recurrence and overall survival. Radiology 289(3), 677–685 (2018).
  • Kim TH , Firat C , Thompson HM et al. Extramural venous invasion and tumor deposit at diffusion-weighted MRI in patients after neoadjuvant treatment for rectal cancer. Radiology 308(2), e230079 (2023).
  • Ahn JH , Kim SH , Son JH , Jo SJ . Added value of diffusion-weighted imaging for evaluation of extramural venous invasion in patients with primary rectal cancer. Br. J. Radiol. 92(1096), 20180821 (2019).
  • Bae JS , Kim SH , Hur BY et al. Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: multi-readers’ diagnostic performance. Eur. Radiol. 29(8), 4379–4388 (2019).
  • Zhu H , Wei Z , Huang W , Chen Z . Application value of diameter change of superior rectal vein and inferior mesenteric vein by CT examination in the efficacy evaluation of neoadjuvant therapy for locally advanced rectal cancer. Chinese J. Digest. Surg. 08, 797–802 (2019).
  • Sauer R , Becker H , Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N England J. Med. 351(17), 1731–1740 (2004).
  • Gerard JP , Conroy T , Bonnetain F et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J. Clin. Oncol. 24(28), 4620–4625 (2006).
  • Rodel C , Graeven U , Fietkau R et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, Phase III trial. Lancet Oncol. 16(8), 979–989 (2015).
  • Wang F , Fan W , Peng J et al. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial. Cancer Commun (London). 38(1), 73 (2018).
  • Tang J , Wu X , Bai Y et al. Long-term outcome of oxaliplatin and capecitabine (XELOX) concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer. Journal of Cancer 9(8), 1365–1370 (2018).
  • Agger E , Jorgren F , Joud A , Lydrup ML , Buchwald P . Negative prognostic impact of tumor deposits in rectal cancer: A National Study Cohort. Ann. Surg. 278(3), e526–e533 (2023).